Publications by authors named "Julienne Atsame"

Article Synopsis
  • The shift in onchocerciasis intervention aims from control to elimination of transmission has highlighted the need for better diagnostic tools in low-prevalence settings, a focus area not previously addressed in large-scale ivermectin mass drug administrations (MDA).
  • A comprehensive study in Gabon in 2015 involved 5,829 participants, gathering data through skin-snip and blood tests to assess the presence of microfilariae and IgG4 antibodies against the Ov16 antigen.
  • Results showed varying detection rates across diagnostics: skin-snip microscopy (8%), Ov16 RDT (9%), and Ov16 ELISA (12%), providing valuable data for policymakers and test manufacturers to evaluate community-level transmission status and improve MDA strategies
View Article and Find Full Text PDF

Background: The aim of this study was to determine performance indicators of thick blood smears of 50 µl (TBS-50), following the Standards for the Reporting of Diagnostic Accuracy Studies-Bayesian Latent Class Model (STARD-BLCM) guidelines. TBS-50 was compared with two common parasitological techniques-direct examination of 10 µl blood and a leukoconcentration of 5 ml-for the diagnosis of microfilaremic loiasis.

Methods: The study population was recruited among patients of the Department of Parasitology-Mycology-Tropical Medicine over a period of 1 year.

View Article and Find Full Text PDF

Control and treatment programs (CDTI) have been set up nationally in all endemic countries to overcome the impact of onchocerciasis on the affected populations. However, Gabon must still succeed in setting up real onchocerciasis control programs. Here, various database articles have been used to provide the scientific community with a summary document showing the mapping of this disease in Gabon.

View Article and Find Full Text PDF

The elimination of onchocerciasis through community-based Mass Drug Administration (MDA) of ivermectin (Mectizan) is hampered by co-endemicity of Loa loa, as individuals who are highly co-infected with Loa loa parasites can suffer serious and occasionally fatal neurological reactions from the drug. The test-and-not-treat strategy of testing all individuals participating in MDA has some operational constraints including the cost and limited availability of LoaScope diagnostic tools. As a result, a Loa loa Antibody (Ab) Rapid Test was developed to offer a complementary way of determining the prevalence of loiasis.

View Article and Find Full Text PDF

The lack of a WHO-recommended strategy for onchocerciasis treatment with ivermectin in hypo-endemic areas co-endemic with loiasis is an impediment to global onchocerciasis elimination. New loiasis diagnostics (LoaScope; Loa antibody rapid test) and risk prediction tools may enable safe mass treatment decisions in co-endemic areas. In 2017-2018, an integrated mapping strategy for onchocerciasis, lymphatic filariasis (LF), and loiasis, aimed at enabling safe ivermectin treatment decisions, was piloted in Gabon.

View Article and Find Full Text PDF

In order to follow the Preventive Chemotherapy (PC) for the transmission control as recommended by WHO, Gabon initiated in 2014 the mapping of Schistosomiasis and Soil Transmitted Helminthiasis (STH). Here, we report the results of the Northern and Eastern health regions, representing a third of the land area and 12% of its total population. All nine departments of the two regions were surveyed and from each, five schools were examined with 50 schoolchildren per school.

View Article and Find Full Text PDF